Flovent Aerosol, Metered
Product Images NDC 50090-0934

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 50090-0934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Floventhfa Spl Graphic 01)

Chemical structure diagram of fluticasone propionate, the active ingredient in FLOVENT HFA 220 mcg/1 aerosol inhaler by A-S Medication Solutions.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Floventhfa Spl Graphic 02)

A line graph showing percent change from baseline in FEV1 over a 12-week period comparing placebo and FLOVENT HFA 88 mcg twice daily. The x-axis represents weeks, and the y-axis shows percent change in FEV1. FLOVENT HFA shows a greater increase in FEV1 compared to placebo throughout the study timeline.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Floventhfa Spl Graphic 03)

A line graph showing the percentage change from baseline in FEV1 over a 12-week period with an endpoint measurement. Four groups are compared: placebo, and FLOVENT HFA at doses of 88 mcg, 220 mcg, and 440 mcg twice daily. The y-axis indicates percentage change in FEV1, and the x-axis shows time in weeks. Higher doses of FLOVENT HFA show greater improvement in FEV1 compared to placebo.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Floventhfa Spl Graphic 04)

Bar chart showing the percentage of subjects with 100% reduction in dose and percentage with increase in dose, comparing placebo, FLOVENT HFA 440 mcg twice daily, and FLOVENT HFA 880 mcg twice daily. FLOVENT HFA groups show higher reduction percentages than placebo, while placebo has higher percentage of subjects with increased dose.*

FDA Label Image

Figure A (Floventhfa Spl Graphic 05)

Illustration showing components of FLOVENT HFA inhaler including metal canister, dark orange plastic actuator, dark orange mouthpiece with an integrated counter, and a separate peach-colored cap that fits over the mouthpiece.*

FDA Label Image

Figure B (Floventhfa Spl Graphic 06)

An instructional illustration showing a person removing the protective cap from the mouthpiece of an aerosol metered inhaler, held in the opposite hand, demonstrating preparation for use.*

FDA Label Image

Fgure C (Floventhfa Spl Graphic 07)

An instructional illustration showing a person using a metered-dose inhaler. The image depicts the person holding the inhaler upright, with a finger pressing down on the top to release a spray, indicated by an arrow and a visible mist from the mouthpiece. A removed cap for the inhaler lies nearby.*

FDA Label Image

Figure D (Floventhfa Spl Graphic 08)

An illustration depicting a hand holding an aerosol inhaler device. The inhaler shows a visible dose counter displaying the number 120, indicating the remaining doses in the inhaler.*

FDA Label Image

Figure E (Floventhfa Spl Graphic 09)

An instructional illustration showing the mouthpiece-down position for using an inhaler. It highlights the dark orange mouthpiece and a separate peach-colored cap on a flat surface, with a hand holding the device upright.*

FDA Label Image

Figure F (Floventhfa Spl Graphic 10)

An instructional illustration showing a side profile of a person exhaling forcefully, with the text 'Breathe out as much air as you can' and a dashed arrow indicating the direction of exhalation from the mouth.*

FDA Label Image

Figure G (Floventhfa Spl Graphic 11)

An instructional illustration showing how to use a metered dose inhaler. The image depicts a person holding the inhaler near their mouth, with an arrow indicating to push down on the inhaler while breathing in the medication through the mouthpiece.*

FDA Label Image

Figure H (Floventhfa Spl Graphic 12)

An instructional illustration showing a person rinsing their mouth by spitting water into a sink, with a faucet and a glass of water visible nearby. This diagram is likely related to rinsing after inhalation use.*

FDA Label Image

Figure I (Floventhfa Spl Graphic 13)

An instructional illustration showing two scenarios of using a metered-dose inhaler. The top panel labeled 'Not blocked' depicts correct inhaler use, with aerosol medication spraying outward. The bottom panel labeled 'Blocked' shows incorrect use, with the inhaler nozzle partially obstructed, preventing proper spray release.*

FDA Label Image

Floventhfa Spl Graphic 14

An instructional diagram showing a hand using a cotton swab or similar tool to clean or adjust the mouthpiece of an inhaler device. The image depicts the inhaler front with an arrow indicating a circular motion to be performed on the mouthpiece area.*

FDA Label Image

Label Image (Lbl500900934)

FLOVENT HFA 220 MCG aerosol inhalation label by A-S Medication Solutions. The label includes the product NDC 50090-0934-0 and states the product contains 120 metered actuations per container. It includes dosing instructions to shake well and spray twice away from the face for priming. The inhaler is for oral use, with a 30-second breath hold recommended.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.